Oncology Institute, Inc. (TOI) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$36.08M | +40.0% |
| 2024 | -$60.12M | +21.9% |
| 2023 | -$77.02M | +6.0% |
| 2022 | -$81.95M | -78.7% |
| 2021 | -$45.86M | -459.4% |
| 2020 | -$8.20M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$36.08M | +40.0% |
| 2024 | -$60.12M | +21.9% |
| 2023 | -$77.02M | +6.0% |
| 2022 | -$81.95M | -78.7% |
| 2021 | -$45.86M | -459.4% |
| 2020 | -$8.20M | — |